Alzheimer's Disease - The Puzzles, The Partners, The Path Forward
26 November, 2013 - According to the Alzheimer's Association, a medicine that delays onset of Alzheimer's disease by five years would lower the number of Americans suffering from the disease by nearly half and save $447 billion in related costs, in 2050. A recent forum hosted by the Alzheimer's Association, the Alzheimer's Drug Discovery foundation, and PhRMA, provided an opportunity to evaluate the challenges and opportunities in pre-competitive partnerships, clinical trial enrollment and public policy for the disease.
Innovation.org Highlights the More Than 450 Innovative Medicines in Development for Rare Diseases
30 October, 2013 - This month, Innovation Insights examines the innovative research into new treatments for rare diseases, and highlights the American Association for Cancer Research's 2013 Cancer Progress Report.
The Transforming Power of Innovative Vaccines to Improve Public Health
24 September, 2013 - Vaccines are one of the most remarkable achievements in biomedical science and public health. Scientific advances, such as genomics, are enabling the development of new preventative vaccines, but also therapeutic vaccines for many types of cancer, HIV/AIDS, hepatitis and autoimmune disorders.
Innovation.org Highlights the Nearly 450 Innovative Medicines in Development for Neurological Disorders
31 July, 2013 - This month, Innovation Insights examines the innovative research into new treatments for neurological disorders, and highlights great moments in innovation over the past 100 years.
Innovations in Cancer Improve Outlook for Patients, Build on Previous Advances
28 June, 2013 - Cancer research continues to move forward at a rapid pace—welcome news for the millions of patients and families around the world who continue to be affected by this devastating disease. While cancer remains the second greatest killer in the United States, we have made great strides. News out of the American Society of Clinical Oncology Annual Meeting provided an opportunity to step back and appreciate the progress researchers are making against cancer.
Innovation.org Highlights Arthritis Awareness Month and Progress Against Blood Cancers
31 May, 2013 - This month, Innovation Insights highlights Arthritis Awareness Month, including the innovative research into new arthritis treatments, and examines the medicines in development for blood cancers. Read the newsletter.
Innovative Medicines Improve Life for Older Americans
30 April, 2013 - 30 April, 2013 - Chronic diseases are a principal threat to the health and productivity of older Americans, as well as a major driver of rising health care costs. As highlighted last week in a report released by the Partnership to Fight Chronic Disease, almost $2 out of $3 spent on health care in the U.S. is directed toward care for the 27% of Americans with multiple chronic conditions. America’s biopharmaceutical companies are working to address this need through a robust pipeline of more than 400 new medicines in development that target many of the conditions affecting older Americans.
Innovation.org Highlights Progress Against Heart Disease and Cancer
28 February, 2013 - This month, Innovation Insights highlights American Heart Month and World Cancer Day, and examines the progress being made against two devastating diseases.
Robust Biopharmaceutical Pipeline Offers New Hope for Patients
31 January, 2013 - The biopharmaceutical pipeline is innovative and robust, with a high proportion of potential first-in-class medicines and therapies targeting diseases with limited treatment options. A recent report from the Analysis Group reveals that more than 5,000 new medicines are in the pipeline globally. Of these, 70 percent are potential first-in-class medicines, which could provide exciting new approaches to treating disease.